Alistair Macdonald
Alistair is an Operating Partner with GHO Capital, and works as a Board member and Advisor to several organizations in the Pharmaceutical Service arena. Alistair was formally the Chief Executive Officer at Syneos Health and has over 20 years experience in the biopharmaceutical industry and served as the Chair of the Association of Clinical Research […]
Graham Clarke
Graham holds a number of non-executive positions including: Non-Executive member of the Department of Health and Social Care (“DHSC”), sitting on its Audit & Risk Committee. Non-Executive Director of the NHS Health Research Authority (“HRA”), the regulator of human research in England and Wales. Chairman of the board at Herts Urgent Care, a Social Enterprise […]
Lynne Robb
Lynne began her career as a Chartered Accountant when she trained with Arthur Andersen & Co in London and Leeds. She then moved into the corporate world, working for many years with Tate & Lyle, where she had several Financial leadership roles. She also worked on major integrations and mergers, which led her to join […]
Dr Robin Brown
Robin was appointed Chairman of the Medicines Discovery Catapult in July 2018. Most recently he was the Chief Executive Officer of KWS BioTest, a specialist immunology-based contract research organisation. In January 2018 KWS was acquired by Charles River Laboratories. Immediately before joining KWS, Robin spent eight years as a venture partner at Advent Healthcare Ventures […]
Professor Chris Reilly
Chris is an expert on the discovery and early clinical development of new medicines. He was formerly Global Vice President and Head of Project Evaluation at AstraZeneca (AZ) where he made investment recommendations on all lead identification and optimisation projects across all research areas. Chris was also responsible for developing AZ’s research strategy and was […]
Professor Sir Alex Markham
Sir Alex is Professor of Medicine and Director of the MRC Medical Bioinformatics Centre at the University of Leeds. He also works in MRC Centres for Hyperpolarised MRI Imaging and Single-Cell Functional Genomics, as well as an EPSRC Programme on Microfluidic Constructed Architectures for Therapeutic Delivery, in Leeds. Sir Alex has made many contributions to biomedical research. He initially obtained his […]
Professor Carole Longson MBE
Carole is responsible for leading the Research, Medical and Innovation function at the ABPI with a remit to shape and develop UK pharmaceutical science policy and to ensure that the UK remains at the forefront of innovation in medicines research, development and manufacturing now and into the future. Carole brings significant research, academic and pharmaceutical […]
Dr Nicola Heron
Nicola has over 26 years of life science experience, holding senior positions across the public and private sectors in organisations including AstraZeneca and the NHS. With a broad range of experience from research to commercialisation in pharmaceuticals, medical devices and diagnostics, Nicola brings a breadth of experience to her role as Chief Strategy Officer at […]
Professor Chris Molloy
Professor Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. His career began in preclinical research at Glaxo, where he was closely involved with the industrialisation of high throughput discovery. In 2004 he moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean biotech that […]